LONG-TERM SURVIVAL OF SUSTAINED VIROLOGIC RESPONDERS TO PEGYLATED INTERFERON THERAPY FOR CHRONIC HEPATITIS C

被引：0
|
作者：
Chandok, Natasha [1 ]
Kim, W. Ray [1 ]
Pedersen, Rachel [2 ]
Therneau, Terry M. [2 ]
Canterbury, Katherine [1 ]
Stadheim, Linda M. [1 ]
Gross, John B. [1 ]
Poterucha, John J. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA
[2] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Rochester, MN USA
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
119
引用
收藏
页码：359A / 360A
页数：2
相关论文
共 50 条
  • [41] Long-term outcome of chronic hepatitis C treated with interferon
    Hadziyannis, SJ
    Papatheodoridis, GV
    ITALIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 1999, 31 (06): : 459 - 461
  • [42] Persistence of Hepatitis C Virus in Peripheral Blood Mononuclear Cells of Sustained Viral Responders to Pegylated Interferon and Ribavirin Therapy
    Juan F. Gallegos-Orozco
    Jorge Rakela
    Marianne J. Rosati
    Hugo E. Vargas
    Vijayan Balan
    Digestive Diseases and Sciences, 2008, 53 : 2564 - 2568
  • [43] Persistence of hepatitis C virus in peripheral blood mononuclear cells of sustained viral responders to pegylated interferon and ribavirin therapy
    Gallegos-Orozco, Juan F.
    Rakela, Jorge
    Rosati, Marianne J.
    Vargas, Hugo E.
    Balan, Vijayan
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (09) : 2564 - 2568
  • [44] Long-term efficacy of interferon in chronic hepatitis C.
    Berg, T
    Kaul, T
    Heuft, HG
    Naumann, U
    Lobeck, H
    Hopf, U
    HEPATOLOGY, 1997, 26 (04) : 1178 - 1178
  • [45] Serum microRNA-122 level correlates with virologic responses to pegylated interferon therapy in chronic hepatitis C
    Su, Tung-Hung
    Liu, Chen-Hua
    Liu, Chun-Jen
    Chen, Chi-Ling
    Ting, Te-Tien
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Kao, Jia-Horng
    Chen, Ding-Shinn
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (19) : 7844 - 7849
  • [46] Long-term effects of interferon therapy on serum fibrogenesis markers in patients with chronic hepatitis type C; Comparison between responders and nonresponders
    Ishibashi, K
    Kashiwagi, T
    Nagasawa, M
    Toyama, T
    Tanaka, Y
    Ito, A
    Ozaki, S
    Naito, M
    Azuma, M
    GASTROENTEROLOGY, 1996, 110 (04) : A1218 - A1218
  • [47] Repetition of interferon therapy reduces the risk for hepatocellular carcinoma and prolongs the long-term survival in patients with chronic hepatitis C
    Iyoda, K
    Kato, M
    Yuki, N
    Yamamoto, K
    Izumi, Y
    Ueda, T
    Nakamura, T
    Shirahata, N
    Satomi, E
    Michida, T
    Ikeda, M
    GASTROENTEROLOGY, 2005, 128 (04) : A716 - A716
  • [48] Histopathological effects of pegylated and standard interferon in responders and non responders chronic hepatitis C genotype 4
    Esmat, C
    Zalata, K
    Metwally, M
    Hamid, MA
    Abouzied, A
    El Raziky, M
    El Batanony, M
    Strickland, T
    Sjogren, M
    GASTROENTEROLOGY, 2004, 126 (04) : A723 - A723
  • [49] Resolution of fibrosis in hepatitis c patients with sustained response to interferon: Long-term effects of interferon therapy on histological improvement
    Shiratori, Y
    Yoshida, H
    Omata, M
    LIVER CIRRHOSIS, 2001, : 56 - 64
  • [50] Humoral immune response in hepatitis C infection: Fall in anti-HCV levels among long-term sustained responders to interferon therapy.
    Lau, DT
    Maertens, G
    Hoofnagle, JH
    HEPATOLOGY, 1999, 30 (04) : 500A - 500A
12345